XIPERE
Total Payments
$1.1M
Transactions
4,431
Doctors
1,574
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $175,710 | 1,083 | 573 |
| 2023 | $227,362 | 1,369 | 747 |
| 2022 | $559,433 | 1,827 | 872 |
| 2021 | $78,460 | 122 | 73 |
| 2020 | $37,217 | 30 | 16 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $624,256 | 298 | 57.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $224,086 | 237 | 20.8% |
| Food and Beverage | $134,424 | 3,751 | 12.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $63,518 | 15 | 5.9% |
| Travel and Lodging | $28,105 | 106 | 2.6% |
| Space rental or facility fees (teaching hospital only) | $3,500 | 1 | 0.3% |
| Education | $291.87 | 23 | 0.0% |
Top Doctors Receiving Payments for XIPERE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Ophthalmology | Atlanta, GA | $89,694 | 76 |
| , M.D | Ophthalmology | San Antonio, TX | $61,338 | 61 |
| , M.D | Ophthalmology | Waltham, MA | $59,923 | 59 |
| , MD | Uveitis and Ocular Inflammatory Disease | Parker, CO | $43,143 | 56 |
| , MD | Ophthalmology | Miami, FL | $39,277 | 40 |
| , MD | Ophthalmology | Newark, NJ | $38,288 | 23 |
| , MD | Ophthalmology | Boston, MA | $35,210 | 40 |
| , M.D | Ophthalmology | Waltham, MA | $33,308 | 39 |
| , MD | Ophthalmology | Winston Salem, NC | $31,517 | 44 |
| , M.D | Ophthalmology | Ft Lauderdale, FL | $29,338 | 38 |
| Seenu Hariprasad | Ophthalmology | Burr Ridge, IL | $24,229 | 11 |
| , M.D | Ophthalmology | Phoenix, AZ | $22,390 | 60 |
| , M.D | Ophthalmology | Dallas, TX | $21,232 | 28 |
| , M.D | Ophthalmology | Cleveland, OH | $20,107 | 26 |
| , M.D | Ophthalmology | Lexington, KY | $18,142 | 31 |
| , MD | Ophthalmology | Stanford, CA | $18,121 | 19 |
| , M.D | Ophthalmology | Chicago, IL | $17,589 | 23 |
| , MD | Ophthalmology | Houston, TX | $17,262 | 34 |
| , M.D | Ophthalmology | Santa Ana, CA | $15,244 | 31 |
| , MD | Retina Specialist | Mcallen, TX | $14,484 | 20 |
| , M.D | Retina Specialist | Manchester, CT | $14,395 | 32 |
| , MD | Retina Specialist | Saint Louis, MO | $13,996 | 19 |
| , M.D | Ophthalmology | Indianapolis, IN | $13,344 | 18 |
| , MD, PHD | Ophthalmology | Sacramento, CA | $13,335 | 23 |
| , M.D | Ophthalmology | Chesterfield, MO | $12,645 | 15 |
Ad
Manufacturing Companies
Product Information
- Type Drug
- Total Payments $1.1M
- Total Doctors 1,574
- Transactions 4,431
About XIPERE
XIPERE is a drug associated with $1.1M in payments to 1,574 healthcare providers, recorded across 4,431 transactions in the CMS Open Payments database. The primary manufacturer is Bausch & Lomb Americas Inc..
Payment data is available from 2020 to 2024. In 2024, $175,710 was paid across 1,083 transactions to 573 doctors.
The most common payment nature for XIPERE is "Consulting Fee" ($624,256, 57.9% of total).